Queen’s researchers receive federal funding for novel, patient-oriented cancer treatments

Queen’s researchers receive federal funding for novel, patient-oriented cancer treatments

Featured in the Queen's Gazette, Dr. Allingham along with co-investigators P. Andrew Evans (Department of Chemistry) and Andrew Craig (The Queen's Cancer Research Institute), will receive $497,500 over the three years. The federal financing will fund the development and pre-clinical testing of new cancer fighting drugs that disturb a key protein required for cancer cells to spread; 90% of cancer-related deaths occur by the spread of cancer cells within the body and new therapies like these will greatly improve the survival rates of cancer patients. For more information on the CHRP grants, please visit the website.